Open AccessResponses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer
Author(s) -
Stacy L. Moulder,
John W. Moroney,
Thorunn Helgason,
Jennifer J. Wheler,
Daniel J. Booser,
Constance T. Albarracin,
Phuong K. Morrow,
Kimberly B. Koenig,
Razelle Kurzrock
Publication year - 2011
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2010.34.0604
Subject(s) - medicine , bevacizumab , temsirolimus , oncology , breast cancer , stem cell , doxorubicin , cancer research , cancer , chemotherapy , discovery and development of mtor inhibitors , pi3k/akt/mtor pathway , genetics , biology , apoptosis , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom